CARBAMAZEPINE VIATRIS L.P. 400 mg, scored tablet with extended release 30 tablets
Active ingredients: Carbamazepin
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet with extended release30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CARBAMAZEPINE VIATRIS L.P. 400 mg, comprimé sécable à libération prolongée
- Pharmaceutical form
- comprimé sécable à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC de 30 comprimé(s) avec fermeture de sécurité enfant
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Oct 2000
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66857620CIP73530514CIP133400935305145Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CARBAMAZÉPINEcomprimé | 400 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.